Liberum Capital reissued their buy rating on shares of Victrex (LON:VCT) in a report released on Monday, February 5th. The brokerage currently has a GBX 2,770 ($38.27) price target on the stock.
A number of other research firms also recently weighed in on VCT. Berenberg Bank reissued a buy rating and set a GBX 2,600 ($35.92) target price on shares of Victrex in a research report on Tuesday, December 5th. Barclays decreased their target price on shares of Victrex from GBX 2,350 ($32.47) to GBX 2,270 ($31.36) and set an equal weight rating for the company in a research report on Tuesday, November 28th. Peel Hunt downgraded shares of Victrex to a hold rating and set a GBX 2,300 ($31.78) target price for the company. in a research report on Tuesday, October 31st. Deutsche Bank reissued a hold rating and set a GBX 2,200 ($30.40) target price on shares of Victrex in a research report on Thursday, January 4th. Finally, JPMorgan Chase & Co. increased their target price on shares of Victrex from GBX 2,250 ($31.09) to GBX 2,580 ($35.65) and gave the company a neutral rating in a research report on Monday, January 8th. Eight analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of Hold and an average target price of GBX 2,368.80 ($32.73).
Victrex (LON VCT) opened at GBX 2,486 ($34.35) on Monday. Victrex has a 52 week low of GBX 1,826 ($25.23) and a 52 week high of GBX 2,772 ($38.30). The stock has a market capitalization of $2,150.00 and a P/E ratio of 2,143.10.
The firm also recently declared a dividend, which will be paid on Friday, February 16th. Shareholders of record on Thursday, February 1st will be issued a dividend of GBX 109.60 ($1.51) per share. This represents a dividend yield of 4.31%. This is a boost from Victrex’s previous dividend of $12.20. The ex-dividend date of this dividend is Thursday, February 1st.
In related news, insider Martin Court sold 441 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of GBX 2,618 ($36.17), for a total value of £11,545.38 ($15,951.06). Insiders have acquired a total of 14 shares of company stock worth $36,018 over the last 90 days.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/13/victrexs-vct-buy-rating-reaffirmed-at-liberum-capital.html.
Victrex Company Profile
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.